Literature DB >> 28522046

Generic, twice-daily minocycline versus branded, extended-release minocycline for acne: A retrospective comparison of treatment escalation.

Preeta Gupta1, Timothy Shin2, Jennifer Sopkovich3, Susan Massick3, Benjamin H Kaffenberger4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28522046      PMCID： PMC5439298          DOI： 10.1016/j.jaad.2017.01.013

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.

Authors:  Young H Lee; Guodong Liu; Diane M Thiboutot; Douglas L Leslie; Joslyn S Kirby
Journal:  J Am Acad Dermatol       Date:  2014-04-13       Impact factor: 11.527

Review 2.  Minocycline for acne vulgaris: efficacy and safety.

Authors:  Sarah E Garner; Anne Eady; Cathy Bennett; John Norman Newton; Karen Thomas; Catalin Mihai Popescu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 3.  Medical adherence to acne therapy: a systematic review.

Authors:  Stephanie Snyder; Ian Crandell; Scott A Davis; Steven R Feldman
Journal:  Am J Clin Dermatol       Date:  2014-04       Impact factor: 7.403

4.  Large-scale worldwide observational study of adherence with acne therapy.

Authors:  Brigitte Dréno; Diane Thiboutot; Harald Gollnick; Andrew Y Finlay; Alison Layton; James J Leyden; Eric Leutenegger; Montserrat Perez
Journal:  Int J Dermatol       Date:  2010-04       Impact factor: 2.736

5.  Safety and efficacy of a new extended-release formulation of minocycline.

Authors:  Alan B Fleischer; Scott Dinehart; Dow Stough; R Todd Plott
Journal:  Cutis       Date:  2006-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.